OXY-1-1

........10........20........30........40........50........60........70........80........90.......100.......110.......120.......130.......140.......150.......160.......170.......180.......190.......200.......210.......220.......230.......240.......250.......260.......270.......280.......290. MLKSSWRKTALMAAAAVPLLLASGSLWASADAIQQKLADLEKRSGGRLGVALINTADDSQTLYRGDERFAMCSTGKVMAAAAVLKQSESNPEVVNKRLEIKKSDLVVWSPITEKHLQSGMTLAELSAAALQYSDNTAMNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDKRDTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWAVGDKTGAGDYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEGL

OXY-1-2	........................................................................................................................................................................................................................................V......G...................................................	99.31 %
OXY-1-3	...............................................................................................................................................................................................................................................G...................................................	99.66 %
OXY-1-4	..............-.........................................................................................................................................................................................................................V..........................................................	99.31 %
OXY-1-6	.....................................................................................................................................................................................................................................................................P...............K.............	99.31 %
OXY-1-7	........................................................................................................................................................................................................................................V..........................................................	99.66 %
OXY-1-8	..............-....................................................................................................................................................................................................................................................................................	99.66 %
OXY-1-9	...........................................................................................D............................................................................................................................................V......G...................................................	98.97 %
OXY-1-10	.................................................I.................................................................................................................................................................................................................................................	99.66 %
OXY-1-11	...............................................................................................................................................................................................................................................G.................................................R.	99.31 %
OXY-1-12	......H.......-....................................................................................................................................................................................................................................................................................	99.31 %
OXY-1-13	..............-.........................................................................................................................................................................................................................V.......................................................K..	98.97 %
OXY-1-14	.............................V...H..........................................................................................................................................................................................E...........V......G...................................................	98.28 %
OXY-1-15	............................................................................................................................................................................................T......................................................................................................	99.66 %
OXY-1-16	..............V..........................................N.H...................................................A...................................................................................................................................................................................	98.63 %
OXY-1-17	.........................................................N.H...................................................A...................................................................................................................................................................................	98.97 %
OXY-1-18	.....................................................................................R..................................................................................................................................................V..........................................................	99.31 %
OXY-1-19	...........................................................................................................................................................................M.......................................................................................................................	99.66 %

Last updated: January 08, 2024.

If you use BLDB please cite: Naas, T.; Oueslati, S.; Bonnin, R. A.; Dabos, M. L.; Zavala, A.; Dortet, L.; Retailleau, P.; Iorga, B. I., Beta-Lactamase DataBase (BLDB) – Structure and Function. J. Enzyme Inhib. Med. Chem. 2017, 32, 917-919.

The development of the BLDB database is funded in part by the JPIAMR transnational project DesInMBL, the Région Ile-de-France (DIM Malinf) and the Laboratory of Excellence in Research on Medication and Innovative Therapeutics (LERMIT).

Contact: contact@bldb.eu

Live statistics (since December 3rd, 2023)